Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 21;15(6):e40717.
doi: 10.7759/cureus.40717. eCollection 2023 Jun.

A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae

Affiliations

A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae

Harshmeet Singh Gujral Jr et al. Cureus. .

Abstract

Background Multisystem involvement in coronavirus disease 2019 (COVID-19) is known since the beginning of the pandemic, and post-COVID-19 sequelae have often been reported. The term 'long Covid' encompasses these signs and symptoms. The aim of our study was to study different after-effects which patients endured within 12 months after recovery from acute COVID-19 and to study the various risk predictors. Methods This was a longitudinal observational study of a cohort of 146 patients who recovered from COVID-19 illness. Patients were enrolled during the first four weeks of the onset of their illness, and a monthly follow-up assessment was done for six months that included a detailed history of persistent or new symptoms, new illnesses diagnosed, and complete biochemical, pulmonary, cardiac, neurological and psychiatric evaluation, both objective and subjective. A final follow-up was also done at the end of one year of enrolment. Based on the patient's self-reported history and our multi-system assessment, recorded sequelae were classified according to the involved organ system. These were correlated with possible risk predictors and statistically significant associations were established. Results One hundred and twenty subjects out of 146 total subjects qualified for final analysis. Pulmonary sequelae (48/120; 40%) were the most followed by psychiatric (30/120; 25%), neurological (26/120; 21.7%), and opportunistic infections (7/120; 5.8%). A total of 39/120 (32.1%) cases complained of prolonged dyspnoea. Six out of 120 i.e. 5% of study participants had new-onset diabetes. Twenty-six out of 120 (21.7%) had radiological signs of pulmonary fibrosis. Patients with co-morbidities, older age, higher body mass index, and patients with severe disease were found to be at higher risk of developing these sequelae. Poor nutrition, female gender, and hospitalization were predictors of psychiatric sequelae. Diabetes and liberal steroid use during COVID-19 management were predictors of opportunistic fungal infections. Conclusion This study evaluated post-COVID-19 sequalae in-depth both objectively and subjectively. Some specific predictors for specific sequelae were confirmed on statistical correlation. Long-term follow-up of high-risk persons is therefore recommended after the cure of COVID-19.

Keywords: covid; multisystem; pulmonary fibrosis; risk predictors; sequelae.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Pie chart depicting the distribution of various sequelae

References

    1. Coronavirus disease (COVID-19) weekly epidemiological updates and monthly operational updates. [ Jun; 2023 ]. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
    1. Modeling the onset of symptoms of COVID-19. Larsen JR, Martin MR, Martin JD, Kuhn P, Hicks JB. Front Public Health. 2020;8:473. - PMC - PubMed
    1. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220–232. - PMC - PubMed
    1. Persistent symptoms in patients after acute COVID-19. Carfì A, Bernabei R, Landi F. JAMA. 2020;324:603–605. - PMC - PubMed
    1. Post-acute COVID-19 syndrome. Nalbandian A, Sehgal K, Gupta A, et al. Nat Med. 2021;27:601–615. - PMC - PubMed

LinkOut - more resources